BioWorld

March 11, 2010

View Archived Issues

Finding 'Medically Actionable Alleles' in Genomic Haystack

Biotech's Future: BioWorld Gives You 2020 Vision in 2010!

Other News To Note

Stock Movers

Clinic Roundup

Financings Roundup

Facet Biotech Wooed by $722M Acquisition Offer from Abbott

Three months after Biogen Idec Inc. failed to acquire Facet Biotech Corp. for $17.50 per share, Abbott is getting the job done with a $27-per-share offer. (BioWorld Today) Read More

Immunotherapy Still an 'Option,' Transgene-Novartis Deal Proves

NIH changes set industry up for workforce, ideas drought

BioWorld

On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...

Today's news in brief

BioWorld

BioWorld briefs for March 12, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for March 12, 2025

At CROI, HIV cure trials raise hopes for broader applicability

BioWorld

At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...

Hummingbird migrates ADCs, tech to newco Callio’s $187M debut

BioWorld

Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...